Study early warning signs in relapsing-remitting multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with relapsing-remitting multiple sclerosis (RRMS)
- Your MS disability level is low, roughly EDSS 0 to 3.5 (mild to moderate function)
- You do not have metal in your body (for example, a pacemaker or metal dental work like dentures)
- You are not currently newly pregnant, and you can confirm pregnancy status if needed
- You have not recently had a head injury
- You agree to sign consent and follow the study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with relapsing-remitting multiple sclerosis using MRI scans and blood tests. It aims to understand how the disease behaves and what markers in blood and imaging may relate to changes over time.
This study looks at whether MS relapses happen without any signs of new disease activity on an MRI scan. By tracking your symptoms and scans, researchers hope to better understand how MS affects people in real life. If you qualify, you may help improve future treatment decisions.
This study looks at people who are at higher risk for multiple sclerosis (MS), to better understand early changes before MS is diagnosed. It may help doctors identify who is more likely to develop MS and how to monitor them sooner.
This study looks at people with relapsing-remitting multiple sclerosis (RRMS) to find factors that predict disability progression even when they are not having relapses. It may help doctors understand who is at higher risk and guide treatment decisions.
This study tests a simple questionnaire that a nurse will ask you during regular check-ups to help spot signs of an MS relapse early. The goal is to see if this tool makes it easier for you and your care team to manage your MS and catch problems sooner.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.